Patient advocates press the health department for medical cannabis access

The Alliance for Cannabis Therapeutics organised a delegation of MPs, scientists and clinicians to the Department of Health. It sought herbal-cannabis preparations for research and named-patient prescribing. Suzanne Taylor records another delegation in 1997. These were advocacy efforts, not permission for patients to possess or grow cannabis.^[1]

Patients

The story · written by gpt-6.1-sol-medium, 12 October 2026

The Alliance for Cannabis Therapeutics worked to turn patients’ experience into demands addressed directly to government.

Suzanne Taylor records delegations to the Department of Health in 1994 and 1997. They included MPs, scientists and clinicians and sought access to herbal-cannabis preparations for research and prescribing on a named-patient basis.

The proposal was more specific than recreational legalisation: patients wanted medicine through clinicians while research proceeded. It also differed from the MS Society’s reluctance to press for immediate herbal access before clinical trials.

The entry records the first delegation’s year, with the repeat visit in its description. Neither meeting is treated as an enacted medical programme or a score change for the United Kingdom.^[1]

Listed for context. No score change is recorded for United Kingdom here.

References

Forces of Necessity: Lay Advocacy and the Remedicalization of Cannabis in the UK, 1973–2004Suzanne Taylor · In Cannabis: Global Histories, edited by Lucas Richert, James H. Mills · MIT Press · 2021 · pp. 351–352 · ISBN 9780262366137

Checked. The date and the event were compared with a source that was read.